Palliative treatment of poor prognosis patients with malignant gliomas

Authors: Hadziahmetovic, Mersiha; Lo, Simon S; Clarke, James W; Farace, Elena; Cavaliere, Robert

Source: Expert Review of Anticancer Therapy, Volume 8, Number 1, January 2008 , pp. 125-132(8)

Buy & download fulltext article:

Price: $73.00 plus tax (Refund Policy)

Abstract:

High-grade gliomas are the most commonly diagnosed malignant brain tumor in adults. Prognosis can be estimated by examining risk factors, including histology, age and performance status. Postoperative radiation therapy is associated with improved survival and standard treatment includes external beam radiotherapy to a dose of 60 Gy in 30-33 fractions. Patients with poor prognostic features have a more limited benefit from radiotherapy. This article reviews the current state of knowledge on risk stratification and analyzes strategies that can be employed to better individualize treatment for poor-prognosis patients.

Keywords: elderly; glioblastoma multiforme; glioma; hypofractionation; quality of life; radiotherapy

Document Type: Research article

DOI: http://dx.doi.org/10.1586/14737140.8.1.125

Affiliations: 1: Medical Student, The Ohio State University College of Medicine, Ohio State University Medical Center, 300 West 10th Avenue, Ste 083A, Columbus, OH 43210, USA., Email: mersiha.hadziahmetovic@osumc.edu

Publication date: 2008-01-01

More about this publication?

Expert Review of Anticancer Therapy provides expert appraisal and commentary on the major trends in cancer care and highlights the performance of new therapeutic and diagnostic approaches.
Editorial Board
Information for Authors
Submit a Paper
Subscribe to this Title
Information for Advertisers
Terms & Conditions
Information for Librarians
Free Trials
ingentaconnect is not responsible for the content or availability of external websites